Elevai Labs Implements 1-for-200 Reverse Stock Split to Ensure Nasdaq ComplianceNewport Beach, Calif., November 22, 2024 – Elevai Labs Inc. (NASDAQ: ELAB) announced today its decision to execute a 1-for-200 reverse stock split of its common stock, ef

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Elevai Labs’s 8K filing here. Elevai Labs Company Profile (Get Free Report) Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare [...]